- The EXPErimental medicine Route To Success in ALS (EXPERTS-ALS) project aims to rapidly screen potential drugs for evidence that they can slow down damage to the nervous system occurring in people with motor neuron disease
- The results from the EXPERTS study will allow scientists to better prioritise which drugs should go forward for evaluation in larger placebo-controlled trials
- Although EXPERTS on its own cannot confirm long-term benefits of a drug, this approach provides a way to ensure only the most promising drugs proceed to larger, more intensive phase 3 trials
- Led by Professor Chris McDermott from the ÀÖ¾ºÌåÓý of Sheffield and Professor Martin Turner from the ÀÖ¾ºÌåÓý of Oxford, the study involves 11 MND centres across the UK
A groundbreaking drug screening programme is set to accelerate the development of new MND treatments.
The EXPErimental medicine Route To Success in ALS (EXPERTS-ALS) project is a pioneering study which aims to rapidly screen potential drugs for e